• 1. Index of subjects
  J. Chem. Soc. Abstr. 1910 98 ii1267
• 2. Index of subjects
  J. Chem. Soc. Abstr. 1923 124 ii1067
• 3. Solvent effects in the nuclear magnetic resonance spectra of organic acids and salts
  J. F. Biellmann,H. Callot Chem. Commun. (London) 1967 458
• 4. Sodium butyrate converts Caco-2 monolayers into a leaky but healthy intestinal barrier resembling that of a newborn infant
  Alina Kondrashina,Andre Brodkorb,Linda Giblin Food Funct. 2021 12 5066
• 5. Hydrotropy, solubilisation and related emulsification processes
  P. A. Winsor Trans. Faraday Soc. 1948 44 376

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Introduction to Sodium Butyrate (CAS No. 156-54-7)

Sodium butyrate, a compound with the chemical formula C?H?NaO?, is a short-chain fatty acid salt that has garnered significant attention in the field of pharmaceuticals and biomedicine. Its CAS number, 156-54-7, uniquely identifies it in scientific literature and industrial applications. This compound is widely recognized for its multifaceted biological activities, making it a subject of extensive research in various therapeutic areas.

The< strong>Sodium butyrate molecule is structurally simple yet biologically potent. As a derivative of butyric acid, it plays a crucial role in cellular metabolism and has been implicated in numerous physiological processes. The compound's ability to modulate gene expression, particularly through histone deacetylase (HDAC) inhibition, has opened new avenues in cancer therapy and neuroprotection. Recent studies have highlighted its potential in enhancing the efficacy of certain chemotherapeutic agents by altering epigenetic landscapes.

One of the most compelling aspects of Sodium butyrate is its impact on gut health. Butyrate is the primary energy source for colonocytes, the cells lining the colon, and its supplementation has been shown to improve gut barrier function and reduce inflammation. This has led to investigations into its role in managing inflammatory bowel diseases (IBDs) such as Crohn's disease and ulcerative colitis. The compound's ability to enhance the production of short-chain fatty acids (SCFAs) also contributes to its anti-inflammatory properties.

In the realm of cancer research, Sodium butyrate has emerged as a promising chemosensitizer. Studies indicate that it can induce apoptosis in tumor cells by activating stress signaling pathways like p53 and caspase-dependent mechanisms. Furthermore, its HDAC inhibitory activity leads to the reactivation of tumor suppressor genes, which are often silenced in cancerous tissues. These findings have spurred clinical trials to evaluate its efficacy in combination with conventional cancer treatments.

The< strong>Sodium butyrate market is expanding rapidly, driven by its therapeutic potential and ease of synthesis. Pharmaceutical companies are investing heavily in developing novel formulations that enhance its bioavailability and targeted delivery. For instance, nanoencapsulation techniques have been explored to improve its penetration across biological barriers, thereby increasing therapeutic efficacy.

Another area where Sodium butyrate shows promise is in neurodegenerative diseases. Preclinical studies suggest that it can protect against neurotoxicity by modulating mitochondrial function and reducing oxidative stress. Its ability to cross the blood-brain barrier has also been investigated, opening possibilities for treating conditions like Alzheimer's and Parkinson's disease. The compound's role in enhancing synaptic plasticity makes it a candidate for cognitive enhancement therapies as well.

The< strong>Sodium butyrate CAS No. 156-54-7 specification ensures high purity and consistency, which are critical for pharmaceutical applications. Manufacturers adhere to stringent quality control measures to guarantee that the product meets international standards such as those set by the International Council for Harmonisation (ICH). This compliance ensures that researchers and clinicians can rely on its biological activity across different batches.

Epidemiological studies have also linked dietary intake of butyric acid to reduced risks of metabolic disorders such as obesity and type 2 diabetes. The< strong>Sodium butyrate supplement form provides an accessible way to increase butyric acid levels in individuals with inadequate dietary intake. Its effects on glucose homeostasis are attributed to its ability to improve insulin sensitivity and enhance pancreatic β-cell function.

The< strong>Sodium butyrate compound's versatility extends beyond human health applications. In agriculture, it has been tested as a feed additive to promote gut health in livestock, leading to improved growth rates and reduced susceptibility to pathogens. This dual utility underscores its broad applicability across multiple sectors.

In conclusion, Sodium butyrate, identified by its CAS number 156-54-7, is a multifunctional compound with significant implications for medicine and biotechnology. Its biological activities span from enhancing gut health to fighting cancer and neurodegenerative diseases, making it a cornerstone of contemporary research efforts. As scientific understanding evolves, so too will the therapeutic applications of this remarkable compound.

• 286367-68-8(Butanoic-2,4-13C2 acid,sodium salt (9CI))
• 286367-75-7(Butanoic-13C4 acid,sodium salt (9CI))
• 6106-21-4(Disodium Succinate Hexahydrate)
• 502-85-2(SODIUM 4-HYDROXYBUTYRATE)
• 150-90-3(Disodium succinate)
• 270564-49-3(Sodium Butyrate-d7)
• 286367-62-2(Butanoic-2-13C acid,sodium salt (9CI))
• 204244-79-1(Sodium Butyrate-3,3,4,4,4-d5)
• 14047-56-4(succinic acid, sodium salt)
• 2922-54-5(Sodium 3-carboxypropanoate)